There were 1,866 press releases posted in the last 24 hours and 442,525 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
OSE Immunotherapeutics Announces Issuance of Canadian Patent and Notice of Allowance of U.S. Patent Protecting CD28-Antagonist Immunotherapy FR104

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image